THE SYRINGE DRIVER. CONTINUOUS SUBCUTANEOUS INFUSIONS IN PALLIATIVE CARE

1:Continuous subcutaneous infusions and syringe drivers
2:Chemistry of Drug Incompatibility and Stability
3:Drug information
4:Symptom control with the syringe driver
5:Compatibility table

The syringe driver is a simple and cost-effective method of delivering a continuous subcutaneous infusion (CSCI). A CSCI provides a safe and effective way of drug administration and can be used to maintain symptom control in patients who are no longer able to take oral medication.

There have been several developments in this field since the third edition of this highly successful book. The text in this edition has been completely revised, incorporating new treatment options and an extensive list of new compatibility data.

This book serves as a valuable reference source, providing comprehensive review of syringe driver use and administration of drugs by CSCI. The first chapter provides an overview of syringe drivers and CSCIs, including a useful array of frequently asked questions. The second chapter provides information about the chemistry of drug incompatibility and degradation. The third chapter comprises revised and referenced information relating to most drugs likely to be administered by CSCI using a syringe driver. The fourth chapter discusses the control of specific symptoms that are often encountered when CSCIs are required. The fifth and final chapter contains an extensive, referenced list of compatibility and stability data relating to drug combinations administered by CSCI.

Features
• Completely up to date with details on all new developments in this field
• The disciplines of pharmacy and medicine continue to complement each other, reinforcing the multi-professional approach that is now a recognised part of quality palliative care
• The only reference source that provides detailed compatibility data for drug combinations administered by CSCI

New to this Edition:
• New chapter describing the pharmaceutical basis of compatibility and stability
• Redesigned compatibility tables, including new data and describing in more detail laboratory data where available
• Revised drug information chapter, including the addition of 3 new monographs

Authors
• Andrew Dickman, Consultant Pharmacist, Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, Lancashire, UK.
• Jennifer Schneider, Associate Professor, Pharmacy, University of Newcastle, Australia